1
Clinical Trials associated with Multiple sarcoma-specific CAR-T cell therapy(Shenzhen Geno-Immune Medical Institute)Safety and Efficacy Evaluation of a Combination Immunotherapy Targeting Sarcomas
The aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines multiple CAR T cells followed by sarcoma vaccines.
100 Clinical Results associated with Multiple sarcoma-specific CAR-T cell therapy(Shenzhen Geno-Immune Medical Institute)
100 Translational Medicine associated with Multiple sarcoma-specific CAR-T cell therapy(Shenzhen Geno-Immune Medical Institute)
100 Patents (Medical) associated with Multiple sarcoma-specific CAR-T cell therapy(Shenzhen Geno-Immune Medical Institute)
100 Deals associated with Multiple sarcoma-specific CAR-T cell therapy(Shenzhen Geno-Immune Medical Institute)